SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2022

SIGNIFICANT ACCOUNTING POLICIES

Schedule of cash, cash equivalents, and restricted cash

	December 31,		December 31,
	2022		2021
Cash and cash equivalents	$	24,535	$	79,423
Restricted cash		—		5,100
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	$	24,535	$	84,523

Schedule of estimated useful lives of the assets

Computers and peripheral equipment	33%
Office furniture and equipment	6% to 20% (mainly 15%)
Leasehold improvements	Over the shorter of the term of the lease, or the useful life of the assets

Schedule of remaining performance obligations which are expected to be satisfied and recognized in future periods

	Year Ending December 31,
					2025 and
	2023		2024		thereafter
Products	$	72	$	12	$	1
Services		36,562		8,711		7,228
	$	36,634	$	8,723	$	7,229

Schedule of significant changes in the deferred revenue

	Year Ended December 31,
	2022		2021
Balance, at the beginning of the year	$	54,616	$	49,136
Revenue recognized		(38,625)		(31,456)
Increase in deferred revenues and customer advances		36,595		36,936
Balance, at the end of the year		52,586		54,616
Less current portion at the end of the year		(36,634)		(41,591)
Long term portion at the end of the year	$	15,952	$	13,025

Schedule of components of AOCI

	Gains (losses)
	on available-
	for-sale		Gains (losses)
	marketable		on cash flow
	securities		hedges		Total
Balance as of January 1, 2022	$	(942)	$	719	$	(223)
Other comprehensive loss before reclassifications, net of tax		(5,434)		(8,979)		(14,413)
Amounts reclassified from AOCI		—		3,683		3,683
Other comprehensive income (loss), net of tax		(5,434)		(5,296)		(10,730)
Balance as of December 31, 2022	$	(6,376)	$	(4,577)	$	(10,953)

	Year Ended December 31,
	2022		2021		2020
Amounts reclassified from AOCI
Cost of revenues	$	814	$	(513)	$	(497)
Research and development, net		1,735		(990)		(937)
Selling and marketing		708		(406)		(375)
General and administrative		426		(229)		(317)
Total operating expenses (income), before income taxes	$	3,683	$	(2,138)	$	(2,126)

Schedule of weighted-average assumptions

	Year Ended December 31,
	2022	2021	2020
Dividend yield	1.13%	0.88%	1.01%-1.17%
Expected volatility	47.64%	49.45%	37.89%-43.09%
Risk-free interest	2.83%	0.5%	0.29%-1.43%
Expected life	4.10 years	3.61 years	3.57-4.23 years

Schedule of share-based compensation expenses

	Year Ended December 31,
		2022		2021	2020
Cost of revenues	$	425	$	411	$	181
Research and development expenses, net		3,481		2,772		1,535
Selling and marketing expenses		6,032		6,170		3,635
General and administrative expenses		5,184		4,811		3,420
Total share-based compensation expenses	$	15,122	$	14,164	$	8,771